Cargando…
Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and occurs mainly in patients with liver cirrhosis. The mammalian target of rapamycin (mTOR) signaling pathway is involved in many hallmarks of cancer including cell growth, metabolism re-programming, proliferation and inhibiti...
Autores principales: | Ferrín, Gustavo, Guerrero, Marta, Amado, Víctor, Rodríguez-Perálvarez, Manuel, De la Mata, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072933/ https://www.ncbi.nlm.nih.gov/pubmed/32070029 http://dx.doi.org/10.3390/ijms21041266 |
Ejemplares similares
-
mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence
por: Guerrero, Marta, et al.
Publicado: (2019) -
Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
por: Amado, Víctor, et al.
Publicado: (2018) -
Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
por: Ferrín, Gustavo, et al.
Publicado: (2015) -
Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal
por: Espejo-Cruz, María Lola, et al.
Publicado: (2021) -
The mTOR Signalling Pathway in Human Cancer
por: Pópulo, Helena, et al.
Publicado: (2012)